Non-alcoholic fatty liver disease (NAFLD) is the build-up of fat in the liver due to factors other than alcohol. It affects about a quarter of the adult population globally, but its cause remains unknown. Now, researchers ...
Sep 19, 2019
1
1662
Researchers at the University of Pittsburgh School of Medicine are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.
Aug 6, 2019
1
284
A possible drug target for chronic liver disease has been identified by an international research collaboration involving a University of Queensland team.
Jun 14, 2019
0
45
Eat as much as you want and not gain weight? Sounds too good to be true.
Apr 23, 2019
0
494
Consuming a high-fat, high-sugar diet causes a harmful accumulation of fat in the liver that may not reverse even after switching to a healthier diet, according to a new study by scientists from Weill Cornell Medicine and ...
Nov 9, 2018
4
1179
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack. This has certainly ...
Oct 17, 2018
0
9
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer ...
Apr 1, 2012
0
0
An international study involving the University of Otago, Christchurch, has found that inadequate vitamin C status is significantly linked to increased body weight—raising public health concerns due to the rising prevalence ...
Jul 16, 2024
0
39
The University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects 1 in 4 ...
Jul 10, 2024
0
0
Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research ...
Jun 2, 2024
0
15
